CureVac N.V. (Nasdaq: CVAC), a pioneering multinational biotech company developing a new class of transformative medicines based on messenger RNA (mRNA), today announced the voting results of the Comp...
Acquisition will strengthen the research, development, manufacturing and commercialization of mRNA-based cancer immunotherapy candidates, marking BioNTech’s next key mile...
On June 4 and 5, 2025, we had the opportunity to participate in two outstanding events that focused on the innovative SME sector in Germany and highlighted the central ro...
Stafford, Texas and Tuebingen, Germany, May 31, 2025 – Immatics N.V. (NASDAQ: IMTX, “Immatics” or the “Company”), a clinical-stage biopharmaceutical company active in the...
TÜBINGEN, Germany/BOSTON, USA – May 15, 2025CureVac N.V. (Nasdaq: CVAC) (“CureVac”), a global biotech company developing a new class of transformative medicines based on...
Houston, Texas and Tuebingen, Germany, May 13, 2025 – Immatics N.V. (NASDAQ: IMTX, “Immatics” or the “Company”), a clinical-stage biopharmaceutical company active in the ...
05/13/2025
| Council of European BioRegions (CEBR)
The Council of European BioRegions (CEBR), the leading network of life science clusters across Europe, is pleased to announce the results of its 2025–2026 Board Elections...
On May 9, 2025, representatives from the life sciences industry in North Carolina and Baden-Württemberg met in Stuttgart for professional exchange. The goal of the event was to explore opportunities f...
Researchers at the University of Stuttgart have used microbial processes to produce environmentally friendly bio-concrete from urine as part of a “wastewater-bio-concrete-fertilizer” value chain. With the project extension granted by the Baden-W...
Tuebingen, Germany, April 15, 2025 – HepaRegeniX GmbH (“HepaRegeniX”), a clinical-stage company advancing novel therapies to treat acute and chronic liver diseases, today...
On April 4, 2025, BioRegio STERN Management GmbH, together with VOELKER & Partner Attorneys, Auditors, and Tax Advisors mbB, hosted an interactive seminar in Stuttgar...
CureVac N.V. (Nasdaq: CVAC) (“CureVac”), a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (“mRNA”...
Researchers led by Dr. Michael Pawlak from NMI Technologie Transfer GmbH (NMI TT) in Reutlingen and Prof. Dr. Hans Neubauer from the Women's Hospital at the University of...
On February 25 and 26, 2024, the official kick-off meeting of the STEP4NAMs project took place in Stuttgart. Our international consortium of ten partners gathered to set the course for promoting New A...
On January 29, 2025, the event "Incisions - Insights: Sustainability in the OR | Green Hospital" took place and was broadcast live from Clinical Anatomy in Tübingen. Here...
We have expanded our tumor diagnostics portfolio with CancerMRD, a service for personalized monitoring of minimal residual disease (MRD) in patients with solid tumors. This tissue-informed test empowe...
During a visit to the Tübingen Women's Clinic, representatives from science and industry had an impressive opportunity: they witnessed "noac," the robotic cockpit from Hellstern, in practical use duri...
Over 1,300 attendees from European research, industry, and politics, with more than 60 sponsors and an extensive program on robotics and artificial intelligence (AI): The...
Metzingen, Germany , January 15, 2025, 1800 ESTNEURA Robotics, cognitive robotics pioneer and the only humanoid robotics company in Germany, today announced it has raised...
